as 11-15-2024 4:00pm EST
CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States. It also provides engineering, program management, supply chain management and kitting, and Maintenance Repair and Overhaul (MRO) services. CPI also acts as a subcontractor to prime aircraft manufacturers in the production of commercial aircraft parts. CPI Aero supplies the E-2D Advanced Hawkeye surveillance aircraft, the A-10 Thunderbolt attack jet, the Gulfstream G650, the UH-60 BLACK HAWK helicopter, and the S-92 helicopter and others.
Founded: | 1980 | Country: | United States |
Employees: | N/A | City: | EDGEWOOD |
Market Cap: | 43.0M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 30.1K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.37 | EPS Growth: | 86.98 |
52 Week Low/High: | $1.30 - $3.54 | Next Earning Date: | 11-13-2024 |
Revenue: | $82,814,085 | Revenue Growth: | -4.86% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Caswell Richard S | CVU | Director | Aug 26 '24 | Buy | $2.88 | 10,000 | $28,800.00 | 132,981 | |
Carey Bond E | CVU | Director | Aug 22 '24 | Buy | $2.70 | 10,000 | $27,000.00 | 175,887 | |
Caswell Richard S | CVU | Director | Aug 22 '24 | Buy | $2.69 | 5,000 | $13,450.21 | 132,981 |
CVU Breaking Stock News: Dive into CVU Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
GlobeNewswire
3 months ago
GlobeNewswire
3 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
5 months ago
GlobeNewswire
5 months ago
GlobeNewswire
5 months ago
The information presented on this page, "CVU CPI Aerostructures Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.